Shares of obesity drugmakers and developers slid on Tuesday after Novo Nordisk forecast a sharper-than-expected sales decline for 2026, underscoring intensifying competition in the blockbuster weight-loss market.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/…
Will they or won’t they? Stocks have moved higher in the last quarter of 2025 as the Federal Reserve started to cut interest rates.
Here is how Archrock Inc. (AROC) and National Energy Services Reunited (NESR) have performed compared to their sector so far this year.
The trends in artificial intelligence (AI) infrastructure are working in Broadcom’s favor. Taiwan Semiconductor is set to benefit from multiple tech trends in the coming years.
